5934b6961c9ca235fe76c3691f40a4c65bea1028
DLBCL_genes.md
| ... | ... | @@ -0,0 +1,914 @@ |
| 1 | +# DLBCL genes |
|
| 2 | + |
|
| 3 | +## Origins of DLBCL genes |
|
| 4 | + |
|
| 5 | +## Tier 1 DLBCL genes |
|
| 6 | + |
|
| 7 | +### *141 total* |
|
| 8 | + |
|
| 9 | +| Gene | Tier | Relevant references | |
|
| 10 | +|:----------------------:|:------------:|:--------------------------------------------------------------------------------:| |
|
| 11 | +| [ACTB](ACTB) | 1, aSHM | Lohr et al. 2012 | |
|
| 12 | +| [ACTG1](ACTG1) | 1, aSHM | Hübschmann et al. 2021 | |
|
| 13 | +| [ARID1A](ARID1A) | 1 | Zhang et al. 2013; Krysiak et al. 2017; Love et al. 2012 | |
|
| 14 | +| [ATM](ATM) | 1 | Beà et al. 2013; Reddy et al. 2017 | |
|
| 15 | +| [B2M](B2M) | 1 | Pararajalingam et al. 2020; Morin et al. 2011 | |
|
| 16 | +| [BCL10](BCL10) | 1 | Morin et al. 2011; Russler-Germain et al. 2023 | |
|
| 17 | +| [BCL2](BCL2) | 1, aSHM | Burkhardt et al. 2022; Morin et al. 2011; Tanaka et al. 1992 | |
|
| 18 | +| [BCL6](BCL6) | 1, aSHM | Morin et al. 2011; Love et al. 2012 | |
|
| 19 | +| [BCL7A](BCL7A) | 1, aSHM | Arthur et al. 2018; Grande et al. 2019; Krysiak et al. 2017 | |
|
| 20 | +| [BCR](BCR) | 1 | | |
|
| 21 | +| [BIRC6](BIRC6) | 1 | Reddy et al. 2017 | |
|
| 22 | +| [BRAF](BRAF) | 1 | Love et al. 2012; Tiacci et al. 2011 | |
|
| 23 | +| [BTG1](BTG1) | 1, aSHM | Burkhardt et al. 2022; Morin et al. 2011 | |
|
| 24 | +| [BTG2](BTG2) | 1, aSHM | Love et al. 2012; Morin et al. 2011 | |
|
| 25 | +| [BTK](BTK) | 1 | Krysiak et al. 2017; Albuquerque et al. 2017 | |
|
| 26 | +| [CARD11](CARD11) | 1 | Wu et al. 2016; Morin et al. 2011; Lenz et al. 2008; Panea et al. 2019 | |
|
| 27 | +| [CASP8](CASP8) | 1 | Reddy et al. 2017 | |
|
| 28 | +| [CCND3](CCND3) | 1 | Morin et al. 2011; Richter et al. 2012 | |
|
| 29 | +| [CD274](CD274) | 1 | Morin et al. 2011 | |
|
| 30 | +| [CD36](CD36) | 1 | Laura Pasqualucci, Trifonov, et al. 2011 | |
|
| 31 | +| [CD58](CD58) | 1 | Morin et al. 2011 | |
|
| 32 | +| [CD70](CD70) | 1 | Morin et al. 2011; Russler-Germain et al. 2023 | |
|
| 33 | +| [CD79B](CD79B) | 1 | Panea et al. 2019; Morin et al. 2011 | |
|
| 34 | +| [CD83](CD83) | 1, aSHM | Morin et al. 2013; Russler-Germain et al. 2023; Panea et al. 2019 | |
|
| 35 | +| [CDKN2A](CDKN2A) | 1 | Morin et al. 2013; Grande et al. 2019 | |
|
| 36 | +| [CIITA](CIITA) | 1, aSHM | Morin et al. 2011 | |
|
| 37 | +| [CREBBP](CREBBP) | 1 | Love et al. 2012; Laura Pasqualucci, Dominguez-Sola, et al. 2011 | |
|
| 38 | +| [CXCR4](CXCR4) | 1, aSHM | Panea et al. 2019; Khodabakhshi et al. 2012; Krysiak et al. 2017 | |
|
| 39 | +| [CXCR5](CXCR5) | 1 | Schmitz et al. 2018 | |
|
| 40 | +| [DAZAP1](DAZAP1) | 1 | Pararajalingam et al. 2020 | |
|
| 41 | +| [DDX3X](DDX3X) | 1 | Schmitz et al. 2012, 2018 | |
|
| 42 | +| [DTX1](DTX1) | 1, aSHM | Schmitz et al. 2018; Panea et al. 2019 | |
|
| 43 | +| [DUSP2](DUSP2) | 1, aSHM | Morin et al. 2013 | |
|
| 44 | +| [EBF1](EBF1) | 1, aSHM | Bohle et al. 2013; Thomas et al. 2023 | |
|
| 45 | +| [EEF1A1](EEF1A1) | 1 | Hübschmann et al. 2021 | |
|
| 46 | +| [EP300](EP300) | 1 | Laura Pasqualucci, Dominguez-Sola, et al. 2011; Panea et al. 2019 | |
|
| 47 | +| [ETS1](ETS1) | 1, aSHM | Panea et al. 2019; Morin et al. 2011 | |
|
| 48 | +| [ETV6](ETV6) | 1, aSHM | Arthur et al. 2018 | |
|
| 49 | +| [EZH2](EZH2) | 1 | Love et al. 2012; Morin et al. 2010 | |
|
| 50 | +| [FAS](FAS) | 1 | Scholl et al. 2007 | |
|
| 51 | +| [FBXO11](FBXO11) | 1 | Hübschmann et al. 2021; Richter et al. 2012 | |
|
| 52 | +| [FBXW7](FBXW7) | 1 | Zhang et al. 2013 | |
|
| 53 | +| [FOXO1](FOXO1) | 1 | Morin et al. 2011; Schmitz et al. 2012 | |
|
| 54 | +| [GNA13](GNA13) | 1 | Morin et al. 2011; Love et al. 2012 | |
|
| 55 | +| [GNAI2](GNAI2) | 1 | Grande et al. 2019; Morin et al. 2013 | |
|
| 56 | +| [GRB2](GRB2) | 1 | Panea et al. 2019; Laura Pasqualucci, Trifonov, et al. 2011 | |
|
| 57 | +| [GRHPR](GRHPR) | 1, aSHM | Arthur et al. 2018 | |
|
| 58 | +| [HIST1H1B](HIST1H1B) | 1, aSHM | Krysiak et al. 2017; Chapuy et al. 2018 | |
|
| 59 | +| [HIST1H1C](HIST1H1C) | 1, aSHM | Panea et al. 2019; Morin et al. 2011 | |
|
| 60 | +| [HIST1H1D](HIST1H1D) | 1, aSHM | Morin et al. 2013; Krysiak et al. 2017 | |
|
| 61 | +| [HIST1H1E](HIST1H1E) | 1, aSHM | Krysiak et al. 2017; Grande et al. 2019; Morin et al. 2013 | |
|
| 62 | +| [HIST1H2AC](HIST1H2AC) | 1, aSHM | Morin et al. 2013; Krysiak et al. 2017 | |
|
| 63 | +| [HIST1H2AM](HIST1H2AM) | 1, aSHM | Krysiak et al. 2017; Panea et al. 2019 | |
|
| 64 | +| [HIST1H2BC](HIST1H2BC) | 1, aSHM | Krysiak et al. 2017; Reddy et al. 2017 | |
|
| 65 | +| [HIST1H2BK](HIST1H2BK) | 1, aSHM | Panea et al. 2019 | |
|
| 66 | +| [HIST1H3B](HIST1H3B) | 1, aSHM | Zhang et al. 2013 | |
|
| 67 | +| [HIST2H2BE](HIST2H2BE) | 1, aSHM | Schmitz et al. 2018 | |
|
| 68 | +| [HLA-A](HLA-A) | 1 | | |
|
| 69 | +| [HLA-B](HLA-B) | 1 | | |
|
| 70 | +| [HLA-C](HLA-C) | 1 | | |
|
| 71 | +| [HLA-DMB](HLA-DMB) | 1 | | |
|
| 72 | +| [HNRNPU](HNRNPU) | 1, aSHM | Panea et al. 2019; Reddy et al. 2017 | |
|
| 73 | +| [HVCN1](HVCN1) | 1 | Krysiak et al. 2017 | |
|
| 74 | +| [IKZF3](IKZF3) | 1 | Morin et al. 2013; Panea et al. 2019 | |
|
| 75 | +| [IL4R](IL4R) | 1, aSHM | Duns et al. 2021 | |
|
| 76 | +| [IRF4](IRF4) | 1, aSHM | Morin et al. 2011 | |
|
| 77 | +| [IRF8](IRF8) | 1, aSHM | Panea et al. 2019; Morin et al. 2011 | |
|
| 78 | +| [ITPKB](ITPKB) | 1, aSHM | Schmitz et al. 2018 | |
|
| 79 | +| [JUNB](JUNB) | 1 | Reddy et al. 2017 | |
|
| 80 | +| [KLF2](KLF2) | 1, aSHM | Laura Pasqualucci, Trifonov, et al. 2011 | |
|
| 81 | +| [KLHL14](KLHL14) | 1 | Zhang et al. 2013 | |
|
| 82 | +| [KLHL6](KLHL6) | 1, aSHM | Panea et al. 2019; Morin et al. 2011 | |
|
| 83 | +| [KMT2C](KMT2C) | 1 | Zhang et al. 2013; Zhang et al. 2014; Zhou et al. 2019 | |
|
| 84 | +| [KMT2D](KMT2D) | 1 | Beà et al. 2013; Grande et al. 2019; Morin et al. 2011 | |
|
| 85 | +| [KRAS](KRAS) | 1 | Lohr et al. 2012 | |
|
| 86 | +| [LCOR](LCOR) | 1 | Arthur et al. 2018 | |
|
| 87 | +| [LTB](LTB) | 1, aSHM | Panea et al. 2019; Chapuy et al. 2018 | |
|
| 88 | +| [MCL1](MCL1) | 1 | Reddy et al. 2017; Panea et al. 2019 | |
|
| 89 | +| [MEF2B](MEF2B) | 1, aSHM | Morin et al. 2011; Beà et al. 2013 | |
|
| 90 | +| [MEF2C](MEF2C) | 1, aSHM | Arthur et al. 2018 | |
|
| 91 | +| [MGA](MGA) | 1 | Zhang et al. 2013 | |
|
| 92 | +| [MPEG1](MPEG1) | 1 | Morin et al. 2013 | |
|
| 93 | +| [MS4A1](MS4A1) | 1, aSHM | Rushton et al. 2020 | |
|
| 94 | +| [MTOR](MTOR) | 1 | Panea et al. 2019; Zhang et al. 2013 | |
|
| 95 | +| [MYC](MYC) | 1, aSHM | L. Pasqualucci et al. 2001; Johnston and Carroll 1992 | |
|
| 96 | +| [MYD88](MYD88) | 1 | Ngo et al. 2011 | |
|
| 97 | +| [MYOM2](MYOM2) | 1 | Laura Pasqualucci, Trifonov, et al. 2011 | |
|
| 98 | +| [NFKBIA](NFKBIA) | 1 | Russler-Germain et al. 2023; Lake et al. 2009 | |
|
| 99 | +| [NFKBIE](NFKBIE) | 1 | Morin et al. 2016; Pararajalingam et al. 2020 | |
|
| 100 | +| [NFKBIZ](NFKBIZ) | 1, noncoding | Morin et al. 2016 | |
|
| 101 | +| [NLRC5](NLRC5) | 1 | | |
|
| 102 | +| [NOL9](NOL9) | 1 | Schmitz et al. 2018 | |
|
| 103 | +| [NOTCH1](NOTCH1) | 1 | Love et al. 2012; Laura Pasqualucci, Trifonov, et al. 2011; Beà et al. 2013 | |
|
| 104 | +| [NOTCH2](NOTCH2) | 1 | Panea et al. 2019; Trøen et al. 2008; Beà et al. 2013 | |
|
| 105 | +| [OSBPL10](OSBPL10) | 1, aSHM | Arthur et al. 2018 | |
|
| 106 | +| [P2RY8](P2RY8) | 1 | Muppidi et al. 2014; Lohr et al. 2012 | |
|
| 107 | +| [PCBP1](PCBP1) | 1 | Schmitz et al. 2012 | |
|
| 108 | +| [PIM1](PIM1) | 1, aSHM | L. Pasqualucci et al. 2001; Burkhardt et al. 2022 | |
|
| 109 | +| [PIM2](PIM2) | 1, aSHM | Arthur et al. 2018 | |
|
| 110 | +| [POU2AF1](POU2AF1) | 1, aSHM | Krysiak et al. 2017 | |
|
| 111 | +| [POU2F2](POU2F2) | 1 | Krysiak et al. 2017; Zhang et al. 2013 | |
|
| 112 | +| [PRDM1](PRDM1) | 1 | Laura Pasqualucci et al. 2006 | |
|
| 113 | +| [PRKDC](PRKDC) | 1 | Hübschmann et al. 2021; Schmitz et al. 2018 | |
|
| 114 | +| [PTEN](PTEN) | 1 | Love et al. 2012 | |
|
| 115 | +| [PTPRD](PTPRD) | 1 | | |
|
| 116 | +| [RB1](RB1) | 1 | Morin et al. 2013; Zhang et al. 2014 | |
|
| 117 | +| [RFX7](RFX7) | 1 | Grande et al. 2019 | |
|
| 118 | +| [RFXAP](RFXAP) | 1 | | |
|
| 119 | +| [RHOA](RHOA) | 1 | Richter et al. 2012 | |
|
| 120 | +| [RRAGC](RRAGC) | 1 | Okosun et al. 2016 | |
|
| 121 | +| [S1PR2](S1PR2) | 1, aSHM | Muppidi et al. 2014; Morin et al. 2011 | |
|
| 122 | +| [SETD1B](SETD1B) | 1 | Reddy et al. 2017 | |
|
| 123 | +| [SF3B1](SF3B1) | 1 | Love et al. 2012 | |
|
| 124 | +| [SGK1](SGK1) | 1, aSHM | Morin et al. 2011 | |
|
| 125 | +| [SIN3A](SIN3A) | 1 | Grande et al. 2019 | |
|
| 126 | +| [SMARCA4](SMARCA4) | 1 | Zhang et al. 2013; Krysiak et al. 2017; Richter et al. 2012; Nadeu et al. 2020 | |
|
| 127 | +| [SOCS1](SOCS1) | 1, aSHM | Morin et al. 2011 | |
|
| 128 | +| [SPEN](SPEN) | 1 | Rossi et al. 2012 | |
|
| 129 | +| [STAT3](STAT3) | 1 | Ohgami et al. 2014 | |
|
| 130 | +| [STAT6](STAT6) | 1 | Yildiz et al. 2015 | |
|
| 131 | +| [TAF1](TAF1) | 1 | Morin et al. 2013 | |
|
| 132 | +| [TBL1XR1](TBL1XR1) | 1 | Mareschal et al. 2016 | |
|
| 133 | +| [TET2](TET2) | 1 | Panea et al. 2019; Albuquerque et al. 2017 | |
|
| 134 | +| [TMEM30A](TMEM30A) | 1 | Morin et al. 2011 | |
|
| 135 | +| [TMSB4X](TMSB4X) | 1, aSHM | Albuquerque et al. 2017 | |
|
| 136 | +| [TNFAIP3](TNFAIP3) | 1 | Compagno et al. 2009 | |
|
| 137 | +| [TNFRSF14](TNFRSF14) | 1 | Cheung et al. 2010 | |
|
| 138 | +| [TOX](TOX) | 1 | Reddy et al. 2017 | |
|
| 139 | +| [TP53](TP53) | 1 | Beà et al. 2013; Wilda et al. 2004; Morin et al. 2011 | |
|
| 140 | +| [TRIP12](TRIP12) | 1 | | |
|
| 141 | +| [TRRAP](TRRAP) | 1 | Parry et al. 2013 | |
|
| 142 | +| [UBE2A](UBE2A) | 1 | Reddy et al. 2017 | |
|
| 143 | +| [UNC5C](UNC5C) | 1 | | |
|
| 144 | +| [USP7](USP7) | 1 | Grande et al. 2019 | |
|
| 145 | +| [VPS13B](VPS13B) | 1 | | |
|
| 146 | +| [WEE1](WEE1) | 1 | Schmitz et al. 2018 | |
|
| 147 | +| [XPO1](XPO1) | 1 | Mareschal et al. 2016 | |
|
| 148 | +| [ZC3H12A](ZC3H12A) | 1 | Arthur et al. 2018 | |
|
| 149 | +| [ZFP36L1](ZFP36L1) | 1, aSHM | Morin et al. 2011; Panea et al. 2019 | |
|
| 150 | +| [ZNF292](ZNF292) | 1 | Zhang et al. 2013 | |
|
| 151 | +| [ZNF608](ZNF608) | 1 | Zhang et al. 2013; Krysiak et al. 2017 | |
|
| 152 | + |
|
| 153 | +## Tier 2 DLBCL genes |
|
| 154 | + |
|
| 155 | +### *185 total* |
|
| 156 | + |
|
| 157 | +| Gene | Tier | Relevant references | |
|
| 158 | +|:----------------------:|:------------:|:-----------------------------------------------------------:| |
|
| 159 | +| [ABI3BP](ABI3BP) | 2 | Morin et al. 2013 | |
|
| 160 | +| [ADAMTS1](ADAMTS1) | 2 | Hübschmann et al. 2021 | |
|
| 161 | +| [AICDA](AICDA) | 2, aSHM | Arthur et al. 2018 | |
|
| 162 | +| [ANKRD12](ANKRD12) | 2 | Hübschmann et al. 2021 | |
|
| 163 | +| [ANKRD17](ANKRD17) | 2 | Reddy et al. 2017 | |
|
| 164 | +| [ARID1B](ARID1B) | 2 | Reddy et al. 2017 | |
|
| 165 | +| [ARID5B](ARID5B) | 2 | Reddy et al. 2017 | |
|
| 166 | +| [ATR](ATR) | 2 | Reddy et al. 2017 | |
|
| 167 | +| [BCL11A](BCL11A) | 2, aSHM | | |
|
| 168 | +| [BCOR](BCOR) | 2 | Nadeu et al. 2020 | |
|
| 169 | +| [BIRC3](BIRC3) | 2, aSHM | Arthur et al. 2018; Beà et al. 2013 | |
|
| 170 | +| [BLK](BLK) | 2, aSHM | | |
|
| 171 | +| [BRINP3](BRINP3) | 2 | Reddy et al. 2017 | |
|
| 172 | +| [BTBD3](BTBD3) | 2 | Reddy et al. 2017 | |
|
| 173 | +| [CADPS2](CADPS2) | 2 | Hübschmann et al. 2021 | |
|
| 174 | +| [CBLB](CBLB) | 2 | Reddy et al. 2017 | |
|
| 175 | +| [CCL4](CCL4) | 2 | Chapuy et al. 2018 | |
|
| 176 | +| [CD22](CD22) | 2 | Reddy et al. 2017 | |
|
| 177 | +| [CD44](CD44) | 2, aSHM | Arthur et al. 2018 | |
|
| 178 | +| [CD74](CD74) | 2, aSHM | Arthur et al. 2018 | |
|
| 179 | +| [CDC73](CDC73) | 2 | Reddy et al. 2017; Love et al. 2012 | |
|
| 180 | +| [CDH9](CDH9) | 2 | Morin et al. 2013 | |
|
| 181 | +| [CHD1](CHD1) | 2 | Reddy et al. 2017 | |
|
| 182 | +| [CHD8](CHD8) | 2 | Reddy et al. 2017; Grande et al. 2019 | |
|
| 183 | +| [CHST2](CHST2) | 2 | Reddy et al. 2017 | |
|
| 184 | +| [CNOT2](CNOT2) | 2 | Hübschmann et al. 2021 | |
|
| 185 | +| [CNTNAP5](CNTNAP5) | 2 | Morin et al. 2013 | |
|
| 186 | +| [COQ7](COQ7) | 2 | Chapuy et al. 2018 | |
|
| 187 | +| [CRIP1](CRIP1) | 2 | Chapuy et al. 2018 | |
|
| 188 | +| [DCAF6](DCAF6) | 2 | Reddy et al. 2017 | |
|
| 189 | +| [DDX10](DDX10) | 2 | Reddy et al. 2017 | |
|
| 190 | +| [DHX16](DHX16) | 2 | Hübschmann et al. 2021 | |
|
| 191 | +| [DICER1](DICER1) | 2 | Reddy et al. 2017 | |
|
| 192 | +| [DNAH5](DNAH5) | 2 | Morin et al. 2013 | |
|
| 193 | +| [DNM2](DNM2) | 2 | Hübschmann et al. 2021 | |
|
| 194 | +| [DNMT3A](DNMT3A) | 2 | Reddy et al. 2017 | |
|
| 195 | +| [DOCK1](DOCK1) | 2 | Chapuy et al. 2018 | |
|
| 196 | +| [DSG4](DSG4) | 2 | Morin et al. 2013 | |
|
| 197 | +| [EIF2AK3](EIF2AK3) | 2, aSHM | | |
|
| 198 | +| [EZR](EZR) | 2, aSHM | | |
|
| 199 | +| [FAM102A](FAM102A) | 2, aSHM | | |
|
| 200 | +| [FAM38B](FAM38B) | 2 | Morin et al. 2013 | |
|
| 201 | +| [FANK1](FANK1) | 2, aSHM | | |
|
| 202 | +| [FAT4](FAT4) | 2 | Zhang et al. 2014; Morin et al. 2013 | |
|
| 203 | +| [FCRL3](FCRL3) | 2, aSHM | | |
|
| 204 | +| [FNBP1](FNBP1) | 2, aSHM | | |
|
| 205 | +| [FNDC1](FNDC1) | 2 | Morin et al. 2013 | |
|
| 206 | +| [FOXC1](FOXC1) | 2 | Schmitz et al. 2018 | |
|
| 207 | +| [FOXP1](FOXP1) | 2, aSHM | Reddy et al. 2017 | |
|
| 208 | +| [FUBP1](FUBP1) | 2 | Reddy et al. 2017 | |
|
| 209 | +| [FUT5](FUT5) | 2 | Chapuy et al. 2018 | |
|
| 210 | +| [GABRA2](GABRA2) | 2 | Chapuy et al. 2018 | |
|
| 211 | +| [GAK](GAK) | 2 | Hübschmann et al. 2021 | |
|
| 212 | +| [GNAS](GNAS) | 2 | Reddy et al. 2017 | |
|
| 213 | +| [GOLGA5](GOLGA5) | 2 | Reddy et al. 2017 | |
|
| 214 | +| [GPC5](GPC5) | 2 | Schmitz et al. 2018 | |
|
| 215 | +| [GSG2](GSG2) | 2 | Schmitz et al. 2018 | |
|
| 216 | +| [HDAC7](HDAC7) | 2 | Morin et al. 2013 | |
|
| 217 | +| [HIST1H2AG](HIST1H2AG) | 2 | Panea et al. 2019; Krysiak et al. 2017; Morin et al. 2013 | |
|
| 218 | +| [HLA-DMA](HLA-DMA) | 2 | | |
|
| 219 | +| [HLA-DQA1](HLA-DQA1) | 2 | Hübschmann et al. 2021 | |
|
| 220 | +| [HNF1B](HNF1B) | 2 | Laura Pasqualucci, Trifonov, et al. 2011 | |
|
| 221 | +| [HNRNPD](HNRNPD) | 2 | | |
|
| 222 | +| [HNRNPH1](HNRNPH1) | 2, noncoding | Pararajalingam et al. 2020 | |
|
| 223 | +| [HRAS](HRAS) | 2 | Reddy et al. 2017 | |
|
| 224 | +| [ID3](ID3) | 2 | Schmitz et al. 2012; Richter et al. 2012 | |
|
| 225 | +| [IER2](IER2) | 2 | Morin et al. 2013 | |
|
| 226 | +| [IFNGR1](IFNGR1) | 2 | Morin et al. 2013 | |
|
| 227 | +| [IGLL5](IGLL5) | 2, aSHM | Russler-Germain et al. 2023; Panea et al. 2019 | |
|
| 228 | +| [IKBKB](IKBKB) | 2 | Reddy et al. 2017 | |
|
| 229 | +| [IKBKE](IKBKE) | 2 | Hübschmann et al. 2021 | |
|
| 230 | +| [IL16](IL16) | 2 | | |
|
| 231 | +| [IL6](IL6) | 2 | Chapuy et al. 2018 | |
|
| 232 | +| [INO80](INO80) | 2 | Zhang et al. 2013 | |
|
| 233 | +| [IRAG2](IRAG2) | 2, aSHM | | |
|
| 234 | +| [IRF1](IRF1) | 2, aSHM | Hübschmann et al. 2021 | |
|
| 235 | +| [JAK1](JAK1) | 2 | Zhang et al. 2013 | |
|
| 236 | +| [JAK3](JAK3) | 2 | Zhang et al. 2013 | |
|
| 237 | +| [KCMF1](KCMF1) | 2 | Reddy et al. 2017 | |
|
| 238 | +| [KLHL21](KLHL21) | 2 | Schmitz et al. 2018 | |
|
| 239 | +| [LAMA5](LAMA5) | 2 | Schmitz et al. 2018 | |
|
| 240 | +| [LAPTM5](LAPTM5) | 2, aSHM | Hübschmann et al. 2021 | |
|
| 241 | +| [LIN54](LIN54) | 2 | Reddy et al. 2017 | |
|
| 242 | +| [LPP](LPP) | 2, aSHM | Arthur et al. 2018 | |
|
| 243 | +| [LRP12](LRP12) | 2 | Hübschmann et al. 2021 | |
|
| 244 | +| [LRRN3](LRRN3) | 2 | Morin et al. 2013 | |
|
| 245 | +| [LYN](LYN) | 2 | Chapuy et al. 2018 | |
|
| 246 | +| [MAGT1](MAGT1) | 2 | Reddy et al. 2017 | |
|
| 247 | +| [MALAT1](MALAT1) | 2, aSHM | Arthur et al. 2018 | |
|
| 248 | +| [MAP2K1](MAP2K1) | 2 | Louissaint et al. 2016; Shin et al. 2015 | |
|
| 249 | +| [MAP4K4](MAP4K4) | 2 | Reddy et al. 2017 | |
|
| 250 | +| [MARK1](MARK1) | 2 | Reddy et al. 2017 | |
|
| 251 | +| [MECOM](MECOM) | 2 | Reddy et al. 2017 | |
|
| 252 | +| [MET](MET) | 2 | Reddy et al. 2017 | |
|
| 253 | +| [MIR142](MIR142) | 2, aSHM | Kwanhian et al. 2012; Grande et al. 2019 | |
|
| 254 | +| [MIR155HG](MIR155HG) | 2, aSHM | | |
|
| 255 | +| [MPDZ](MPDZ) | 2 | Morin et al. 2013 | |
|
| 256 | +| [MSH2](MSH2) | 2 | Reddy et al. 2017 | |
|
| 257 | +| [MSH6](MSH6) | 2 | Reddy et al. 2017 | |
|
| 258 | +| [MYB](MYB) | 2 | Reddy et al. 2017 | |
|
| 259 | +| [MYBPC2](MYBPC2) | 2 | Schmitz et al. 2018 | |
|
| 260 | +| [MYO1E](MYO1E) | 2, aSHM | | |
|
| 261 | +| [N2RF2](N2RF2) | 2 | Hübschmann et al. 2021 | |
|
| 262 | +| [NANOG](NANOG) | 2 | Chapuy et al. 2018 | |
|
| 263 | +| [NAV1](NAV1) | 2 | Chapuy et al. 2018 | |
|
| 264 | +| [NCOA3](NCOA3) | 2, aSHM | | |
|
| 265 | +| [NCOR1](NCOR1) | 2 | Reddy et al. 2017 | |
|
| 266 | +| [NCOR2](NCOR2) | 2 | Schmitz et al. 2012 | |
|
| 267 | +| [NEAT1](NEAT1) | 2, aSHM | Arthur et al. 2018 | |
|
| 268 | +| [NF1](NF1) | 2 | Reddy et al. 2017 | |
|
| 269 | +| [NFKB1](NFKB1) | 2 | | |
|
| 270 | +| [NFKB2](NFKB2) | 2 | Reddy et al. 2017 | |
|
| 271 | +| [NLRP5](NLRP5) | 2 | Morin et al. 2013 | |
|
| 272 | +| [NLRP8](NLRP8) | 2 | Chapuy et al. 2018 | |
|
| 273 | +| [ODZ3](ODZ3) | 2 | Morin et al. 2013 | |
|
| 274 | +| [P2RX5](P2RX5) | 2, aSHM | Morin et al. 2013 | |
|
| 275 | +| [PAPOLG](PAPOLG) | 2 | Schmitz et al. 2018 | |
|
| 276 | +| [PASK](PASK) | 2 | Morin et al. 2013 | |
|
| 277 | +| [PAX5](PAX5) | 2, aSHM | L. Pasqualucci et al. 2001 | |
|
| 278 | +| [PCDHB11](PCDHB11) | 2 | Morin et al. 2013 | |
|
| 279 | +| [PCLO](PCLO) | 2 | Lohr et al. 2012 | |
|
| 280 | +| [PDE4DIP](PDE4DIP) | 2 | Chapuy et al. 2018 | |
|
| 281 | +| [PDS5B](PDS5B) | 2 | Morin et al. 2013; Hübschmann et al. 2021 | |
|
| 282 | +| [PHF6](PHF6) | 2 | Reddy et al. 2017; Thomas et al. 2023 | |
|
| 283 | +| [PIK3CD](PIK3CD) | 2 | Reddy et al. 2017 | |
|
| 284 | +| [PIK3R1](PIK3R1) | 2 | Zhang et al. 2013; Panea et al. 2019 | |
|
| 285 | +| [PKD1](PKD1) | 2 | Morin et al. 2013 | |
|
| 286 | +| [PNPO](PNPO) | 2 | Hübschmann et al. 2021 | |
|
| 287 | +| [POGZ](POGZ) | 2 | Morin et al. 2013 | |
|
| 288 | +| [PPP1R9B](PPP1R9B) | 2 | | |
|
| 289 | +| [PRKCB](PRKCB) | 2 | Morin et al. 2013 | |
|
| 290 | +| [PRPS1](PRPS1) | 2 | Chapuy et al. 2018 | |
|
| 291 | +| [PTMA](PTMA) | 2, aSHM | | |
|
| 292 | +| [PTPN1](PTPN1) | 2, aSHM | | |
|
| 293 | +| [PTPN23](PTPN23) | 2 | Morin et al. 2013 | |
|
| 294 | +| [PTPN6](PTPN6) | 2 | Reddy et al. 2017 | |
|
| 295 | +| [PTPRK](PTPRK) | 2 | Reddy et al. 2017 | |
|
| 296 | +| [RAC2](RAC2) | 2 | Hübschmann et al. 2021; Panea et al. 2019 | |
|
| 297 | +| [RAD9A](RAD9A) | 2 | Chapuy et al. 2018 | |
|
| 298 | +| [RARA](RARA) | 2 | Reddy et al. 2017 | |
|
| 299 | +| [RCC](RCC) | 2, aSHM | | |
|
| 300 | +| [RFTN1](RFTN1) | 2, aSHM | Arthur et al. 2018 | |
|
| 301 | +| [RHEX](RHEX) | 2, aSHM | | |
|
| 302 | +| [RHOH](RHOH) | 2, aSHM | L. Pasqualucci et al. 2001 | |
|
| 303 | +| [RUBCNL](RUBCNL) | 2, aSHM | | |
|
| 304 | +| [RUNX1](RUNX1) | 2 | Reddy et al. 2017 | |
|
| 305 | +| [SAMD9L](SAMD9L) | 2 | Morin et al. 2013 | |
|
| 306 | +| [SARM1](SARM1) | 2 | Morin et al. 2013 | |
|
| 307 | +| [SEL1L3](SEL1L3) | 2, aSHM | | |
|
| 308 | +| [SEPTIN9](SEPTIN9) | 2, aSHM | | |
|
| 309 | +| [SERPINA9](SERPINA9) | 2, aSHM | Arthur et al. 2018 | |
|
| 310 | +| [SETD2](SETD2) | 2 | Zhang et al. 2013 | |
|
| 311 | +| [SETD5](SETD5) | 2 | Reddy et al. 2017 | |
|
| 312 | +| [SIAH2](SIAH2) | 2 | Hübschmann et al. 2021 | |
|
| 313 | +| [SLC34A2](SLC34A2) | 2 | Hübschmann et al. 2021 | |
|
| 314 | +| [SMEK1](SMEK1) | 2 | Chapuy et al. 2018 | |
|
| 315 | +| [SRRM2](SRRM2) | 2 | Morin et al. 2013; Russler-Germain et al. 2023 | |
|
| 316 | +| [ST6GAL1](ST6GAL1) | 2, aSHM | Arthur et al. 2018 | |
|
| 317 | +| [STAT5B](STAT5B) | 2 | Zhang et al. 2013 | |
|
| 318 | +| [SYK](SYK) | 2 | Reddy et al. 2017 | |
|
| 319 | +| [SYPL1](SYPL1) | 2 | Morin et al. 2013 | |
|
| 320 | +| [TAP1](TAP1) | 2 | Schmitz et al. 2018 | |
|
| 321 | +| [TBC1D4](TBC1D4) | 2, aSHM | Arthur et al. 2018 | |
|
| 322 | +| [TCL1A](TCL1A) | 2, aSHM | Grande et al. 2019 | |
|
| 323 | +| [TGFBR2](TGFBR2) | 2 | Reddy et al. 2017 | |
|
| 324 | +| [TIPARP](TIPARP) | 2 | Reddy et al. 2017 | |
|
| 325 | +| [TLR2](TLR2) | 2 | Beà et al. 2013; Chapuy et al. 2018 | |
|
| 326 | +| [TRAF3](TRAF3) | 2 | Laura Pasqualucci, Trifonov, et al. 2011 | |
|
| 327 | +| [TRAF6](TRAF6) | 2 | Hübschmann et al. 2021 | |
|
| 328 | +| [UBE2J1](UBE2J1) | 2, aSHM | | |
|
| 329 | +| [UBR5](UBR5) | 2 | Pararajalingam et al. 2020; Zhang et al. 2013 | |
|
| 330 | +| [UNC5B](UNC5B) | 2 | Hübschmann et al. 2021 | |
|
| 331 | +| [UNC5D](UNC5D) | 2 | | |
|
| 332 | +| [WAC](WAC) | 2 | Reddy et al. 2017 | |
|
| 333 | +| [WDFY3](WDFY3) | 2 | Morin et al. 2013 | |
|
| 334 | +| [WNK1](WNK1) | 2 | Thomas et al. 2023; Hübschmann et al. 2021 | |
|
| 335 | +| [XBP1](XBP1) | 2, aSHM | | |
|
| 336 | +| [YY1](YY1) | 2 | Reddy et al. 2017 | |
|
| 337 | +| [ZBTB7A](ZBTB7A) | 2 | Reddy et al. 2017; Burkhardt et al. 2022 | |
|
| 338 | +| [ZCCHC7](ZCCHC7) | 2, aSHM | Arthur et al. 2018 | |
|
| 339 | +| [ZEB2](ZEB2) | 2 | Zhang et al. 2013 | |
|
| 340 | +| [ZFAT](ZFAT) | 2 | Reddy et al. 2017 | |
|
| 341 | +| [ZFX](ZFX) | 2 | Reddy et al. 2017 | |
|
| 342 | +| [ZNF217](ZNF217) | 2 | Hübschmann et al. 2021 | |
|
| 343 | +| [ZNF423](ZNF423) | 2 | Chapuy et al. 2018 | |
|
| 344 | + |
|
| 345 | +# References |
|
| 346 | + |
|
| 347 | +<div id="refs" class="references csl-bib-body hanging-indent"> |
|
| 348 | + |
|
| 349 | +<div id="ref-albuquerqueEnhancingKnowledgeDiscovery2017a" |
|
| 350 | +class="csl-entry"> |
|
| 351 | + |
|
| 352 | +Albuquerque, Marco A., Bruno M. Grande, Elie J. Ritch, Prasath |
|
| 353 | +Pararajalingam, Selin Jessa, Martin Krzywinski, Jasleen K. Grewal, |
|
| 354 | +Sohrab P. Shah, Paul C. Boutros, and Ryan D. Morin. 2017. “Enhancing |
|
| 355 | +Knowledge Discovery from Cancer Genomics Data with Galaxy.” |
|
| 356 | +*GigaScience* 6 5: 1–13. <https://doi.org/10.1093/gigascience/gix015>. |
|
| 357 | + |
|
| 358 | +</div> |
|
| 359 | + |
|
| 360 | +<div id="ref-arthurGenomewideDiscoverySomatic2018" class="csl-entry"> |
|
| 361 | + |
|
| 362 | +Arthur, Sarah E., Aixiang Jiang, Bruno M. Grande, Miguel Alcaide, Razvan |
|
| 363 | +Cojocaru, Christopher K. Rushton, Anja Mottok, et al. 2018. “Genome-Wide |
|
| 364 | +Discovery of Somatic Regulatory Variants in Diffuse Large <span |
|
| 365 | +class="nocase">B-cell</span> Lymphoma.” *Nature Communications* 9 1: |
|
| 366 | +4001. <https://doi.org/10.1038/s41467-018-06354-3>. |
|
| 367 | + |
|
| 368 | +</div> |
|
| 369 | + |
|
| 370 | +<div id="ref-beaLandscapeSomaticMutations2013" class="csl-entry"> |
|
| 371 | + |
|
| 372 | +Beà, Sílvia, Rafael Valdés-Mas, Alba Navarro, Itziar Salaverria, David |
|
| 373 | +Martín-Garcia, Pedro Jares, Eva Giné, et al. 2013. “Landscape of Somatic |
|
| 374 | +Mutations and Clonal Evolution in Mantle Cell Lymphoma.” *Proceedings of |
|
| 375 | +the National Academy of Sciences* 110 45: 18250–55. |
|
| 376 | +<https://doi.org/10.1073/pnas.1314608110>. |
|
| 377 | + |
|
| 378 | +</div> |
|
| 379 | + |
|
| 380 | +<div id="ref-bohleRoleEarlyBcell2013" class="csl-entry"> |
|
| 381 | + |
|
| 382 | +Bohle, V., C. Döring, M.-L. Hansmann, and R. Küppers. 2013. “Role of |
|
| 383 | +Early <span class="nocase">B-cell</span> Factor 1 EBF1 in Hodgkin |
|
| 384 | +Lymphoma.” *Leukemia* 27 3: 671–79. |
|
| 385 | +<https://doi.org/10.1038/leu.2012.280>. |
|
| 386 | + |
|
| 387 | +</div> |
|
| 388 | + |
|
| 389 | +<div id="ref-burkhardtClinicalRelevanceMolecular2022b" |
|
| 390 | +class="csl-entry"> |
|
| 391 | + |
|
| 392 | +Burkhardt, Birgit, Ulf Michgehl, Jonas Rohde, Tabea Erdmann, Philipp |
|
| 393 | +Berning, Katrin Reutter, Marius Rohde, et al. 2022. “Clinical Relevance |
|
| 394 | +of Molecular Characteristics in Burkitt Lymphoma Differs According to |
|
| 395 | +Age.” *Nature Communications* 13 1: 3881. |
|
| 396 | +<https://doi.org/10.1038/s41467-022-31355-8>. |
|
| 397 | + |
|
| 398 | +</div> |
|
| 399 | + |
|
| 400 | +<div id="ref-chapuyMolecularSubtypesDiffuse2018b" class="csl-entry"> |
|
| 401 | + |
|
| 402 | +Chapuy, Bjoern, Chip Stewart, Andrew J. Dunford, Jaegil Kim, Atanas |
|
| 403 | +Kamburov, Robert A. Redd, Mike S. Lawrence, et al. 2018. “Molecular |
|
| 404 | +Subtypes of Diffuse Large B Cell Lymphoma Are Associated with Distinct |
|
| 405 | +Pathogenic Mechanisms and Outcomes.” *Nature Medicine* 24 5: 679–90. |
|
| 406 | +<https://doi.org/10.1038/s41591-018-0016-8>. |
|
| 407 | + |
|
| 408 | +</div> |
|
| 409 | + |
|
| 410 | +<div id="ref-cheungAcquiredTNFRSF14Mutations2010a" class="csl-entry"> |
|
| 411 | + |
|
| 412 | +Cheung, K.-John J., Nathalie A. Johnson, Joslynn G. Affleck, Tesa |
|
| 413 | +Severson, Christian Steidl, Susana Ben-Neriah, Jacqueline Schein, et al. |
|
| 414 | +2010. “Acquired TNFRSF14 Mutations in Follicular Lymphoma Are Associated |
|
| 415 | +with Worse Prognosis.” *Cancer Research* 70 22: 9166–74. |
|
| 416 | +<https://doi.org/10.1158/0008-5472.CAN-10-2460>. |
|
| 417 | + |
|
| 418 | +</div> |
|
| 419 | + |
|
| 420 | +<div id="ref-compagnoMutationsMultipleGenes2009a" class="csl-entry"> |
|
| 421 | + |
|
| 422 | +Compagno, Mara, Wei Keat Lim, Adina Grunn, Subhadra V. Nandula, Manisha |
|
| 423 | +Brahmachary, Qiong Shen, Francesco Bertoni, et al. 2009. “Mutations of |
|
| 424 | +Multiple Genes Cause Deregulation of <span |
|
| 425 | +class="nocase">NF-kappaB</span> in Diffuse Large <span |
|
| 426 | +class="nocase">B-cell</span> Lymphoma.” *Nature* 459 7247: 717–21. |
|
| 427 | +<https://doi.org/10.1038/nature07968>. |
|
| 428 | + |
|
| 429 | +</div> |
|
| 430 | + |
|
| 431 | +<div id="ref-dunsCharacterizationDLBCLPMBL2021b" class="csl-entry"> |
|
| 432 | + |
|
| 433 | +Duns, Gerben, Elena Viganò, Daisuke Ennishi, Clementine Sarkozy, Stacy |
|
| 434 | +S. Hung, Elizabeth Chavez, Katsuyoshi Takata, et al. 2021. |
|
| 435 | +“Characterization of DLBCL with a PMBL Gene Expression Signature.” |
|
| 436 | +*Blood* 138 2: 136–48. <https://doi.org/10.1182/blood.2020007683>. |
|
| 437 | + |
|
| 438 | +</div> |
|
| 439 | + |
|
| 440 | +<div id="ref-grandeGenomewideDiscoverySomatic2019" class="csl-entry"> |
|
| 441 | + |
|
| 442 | +Grande, Bruno M., Daniela S. Gerhard, Aixiang Jiang, Nicholas B. Griner, |
|
| 443 | +Jeremy S. Abramson, Thomas B. Alexander, Hilary Allen, et al. 2019. |
|
| 444 | +“Genome-Wide Discovery of Somatic Coding and Noncoding Mutations in |
|
| 445 | +Pediatric Endemic and Sporadic Burkitt Lymphoma.” *Blood* 133 12: |
|
| 446 | +1313–24. <https://doi.org/10.1182/blood-2018-09-871418>. |
|
| 447 | + |
|
| 448 | +</div> |
|
| 449 | + |
|
| 450 | +<div id="ref-hubschmannMutationalMechanismsShaping2021b" |
|
| 451 | +class="csl-entry"> |
|
| 452 | + |
|
| 453 | +Hübschmann, Daniel, Kortine Kleinheinz, Rabea Wagener, Stephan H. |
|
| 454 | +Bernhart, Cristina López, Umut H. Toprak, Stephanie Sungalee, et al. |
|
| 455 | +2021. “Mutational Mechanisms Shaping the Coding and Noncoding Genome of |
|
| 456 | +Germinal Center Derived <span class="nocase">B-cell</span> Lymphomas.” |
|
| 457 | +*Leukemia* 35 7: 2002–16. |
|
| 458 | +<https://doi.org/10.1038/s41375-021-01251-z>. |
|
| 459 | + |
|
| 460 | +</div> |
|
| 461 | + |
|
| 462 | +<div id="ref-johnstonCmycHypermutationBurkitt1992" class="csl-entry"> |
|
| 463 | + |
|
| 464 | +Johnston, J. M., and W. L. Carroll. 1992. “C-Myc Hypermutation in |
|
| 465 | +Burkitt’s Lymphoma.” *Leukemia & Lymphoma* 8 6: 431–39. |
|
| 466 | +<https://doi.org/10.3109/10428199209051025>. |
|
| 467 | + |
|
| 468 | +</div> |
|
| 469 | + |
|
| 470 | +<div id="ref-khodabakhshiRecurrentTargetsAberrant2012" |
|
| 471 | +class="csl-entry"> |
|
| 472 | + |
|
| 473 | +Khodabakhshi, Alireza Hadj, Ryan D. Morin, Anthony P. Fejes, Andrew J. |
|
| 474 | +Mungall, Karen L. Mungall, Madison Bolger-Munro, Nathalie A. Johnson, et |
|
| 475 | +al. 2012. “Recurrent Targets of Aberrant Somatic Hypermutation in |
|
| 476 | +Lymphoma.” *Oncotarget* 3 11: 1308–19. |
|
| 477 | +<https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717795/>. |
|
| 478 | + |
|
| 479 | +</div> |
|
| 480 | + |
|
| 481 | +<div id="ref-krysiakRecurrentSomaticMutations2017b" class="csl-entry"> |
|
| 482 | + |
|
| 483 | +Krysiak, Kilannin, Felicia Gomez, Brian S. White, Matthew Matlock, |
|
| 484 | +Christopher A. Miller, Lee Trani, Catrina C. Fronick, et al. 2017. |
|
| 485 | +“Recurrent Somatic Mutations Affecting <span |
|
| 486 | +class="nocase">B-cell</span> Receptor Signaling Pathway Genes in |
|
| 487 | +Follicular Lymphoma.” *Blood* 129 4: 473–83. |
|
| 488 | +<https://doi.org/10.1182/blood-2016-07-729954>. |
|
| 489 | + |
|
| 490 | +</div> |
|
| 491 | + |
|
| 492 | +<div id="ref-kwanhianMicroRNA142Mutated202012b" class="csl-entry"> |
|
| 493 | + |
|
| 494 | +Kwanhian, Wiyada, Dido Lenze, Julia Alles, Natalie Motsch, Stephanie |
|
| 495 | +Barth, Celina Döll, Jochen Imig, et al. 2012. “MicroRNA-142 Is Mutated |
|
| 496 | +in about 20% of Diffuse Large <span class="nocase">B-cell</span> |
|
| 497 | +Lymphoma.” *Cancer Medicine* 1 2: 141–55. |
|
| 498 | +<https://doi.org/10.1002/cam4.29>. |
|
| 499 | + |
|
| 500 | +</div> |
|
| 501 | + |
|
| 502 | +<div id="ref-lakeMutationsNFKBIAEncoding2009" class="csl-entry"> |
|
| 503 | + |
|
| 504 | +Lake, Annette, Lesley A. Shield, Pablo Cordano, Daniel T. Y. Chui, Julie |
|
| 505 | +Osborne, Shauna Crae, Katherine S. Wilson, et al. 2009. “Mutations of |
|
| 506 | +NFKBIA, Encoding IkappaB Alpha, Are a Recurrent Finding in Classical |
|
| 507 | +Hodgkin Lymphoma but Are Not a Unifying Feature of Non-<span |
|
| 508 | +class="nocase">EBV-associated</span> Cases.” *International Journal of |
|
| 509 | +Cancer* 125 6: 1334–42. <https://doi.org/10.1002/ijc.24502>. |
|
| 510 | + |
|
| 511 | +</div> |
|
| 512 | + |
|
| 513 | +<div id="ref-lenzOncogenicCARD11Mutations2008" class="csl-entry"> |
|
| 514 | + |
|
| 515 | +Lenz, Georg, R Eric Davis, Vu N Ngo, Lloyd Lam, Thaddeus C George, |
|
| 516 | +George W Wright, Sandeep S Dave, et al. 2008. “Oncogenic CARD11 |
|
| 517 | +Mutations in Human Diffuse Large B Cell Lymphoma.” *Science* 319 5870: |
|
| 518 | +1676–79. |
|
| 519 | + |
|
| 520 | +</div> |
|
| 521 | + |
|
| 522 | +<div id="ref-lohrDiscoveryPrioritizationSomatic2012a" class="csl-entry"> |
|
| 523 | + |
|
| 524 | +Lohr, Jens G., Petar Stojanov, Michael S. Lawrence, Daniel Auclair, |
|
| 525 | +Bjoern Chapuy, Carrie Sougnez, Peter Cruz-Gordillo, et al. 2012. |
|
| 526 | +“Discovery and Prioritization of Somatic Mutations in Diffuse Large |
|
| 527 | +<span class="nocase">B-cell</span> Lymphoma DLBCL by Whole-Exome |
|
| 528 | +Sequencing.” *Proceedings of the National Academy of Sciences of the |
|
| 529 | +United States of America* 109 10: 3879–84. |
|
| 530 | +<https://doi.org/10.1073/pnas.1121343109>. |
|
| 531 | + |
|
| 532 | +</div> |
|
| 533 | + |
|
| 534 | +<div id="ref-louissaintPediatrictypeNodalFollicular2016a" |
|
| 535 | +class="csl-entry"> |
|
| 536 | + |
|
| 537 | +Louissaint, Abner, Kristian T. Schafernak, Julia T. Geyer, Alexandra E. |
|
| 538 | +Kovach, Mahmoud Ghandi, Dita Gratzinger, Christine G. Roth, et al. 2016. |
|
| 539 | +“Pediatric-Type Nodal Follicular Lymphoma: A Biologically Distinct |
|
| 540 | +Lymphoma with Frequent MAPK Pathway Mutations.” *Blood* 128 8: |
|
| 541 | +1093–1100. <https://doi.org/10.1182/blood-2015-12-682591>. |
|
| 542 | + |
|
| 543 | +</div> |
|
| 544 | + |
|
| 545 | +<div id="ref-loveGeneticLandscapeMutations2012" class="csl-entry"> |
|
| 546 | + |
|
| 547 | +Love, Cassandra, Zhen Sun, Dereje Jima, Guojie Li, Jenny Zhang, Rodney |
|
| 548 | +Miles, Kristy L. Richards, et al. 2012. “The Genetic Landscape of |
|
| 549 | +Mutations in Burkitt Lymphoma.” *Nature Genetics* 44 12: 1321–25. |
|
| 550 | +<https://doi.org/10.1038/ng.2468>. |
|
| 551 | + |
|
| 552 | +</div> |
|
| 553 | + |
|
| 554 | +<div id="ref-mareschalWholeExomeSequencing2016" class="csl-entry"> |
|
| 555 | + |
|
| 556 | +Mareschal, Sylvain, Sydney Dubois, Pierre-Julien Viailly, Philippe |
|
| 557 | +Bertrand, Elodie Bohers, Catherine Maingonnat, Jean-Philippe Jaïs, et |
|
| 558 | +al. 2016. “Whole Exome Sequencing of Relapsed/Refractory Patients |
|
| 559 | +Expands the Repertoire of Somatic Mutations in Diffuse Large <span |
|
| 560 | +class="nocase">B-cell</span> Lymphoma.” *Genes, Chromosomes & Cancer* 55 |
|
| 561 | +3: 251–67. <https://doi.org/10.1002/gcc.22328>. |
|
| 562 | + |
|
| 563 | +</div> |
|
| 564 | + |
|
| 565 | +<div id="ref-morinGeneticLandscapesRelapsed2016" class="csl-entry"> |
|
| 566 | + |
|
| 567 | +Morin, Ryan D., Sarit Assouline, Miguel Alcaide, Arezoo Mohajeri, |
|
| 568 | +Rebecca L. Johnston, Lauren Chong, Jasleen Grewal, et al. 2016. “Genetic |
|
| 569 | +Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas.” |
|
| 570 | +*Clinical Cancer Research: An Official Journal of the American |
|
| 571 | +Association for Cancer Research* 22 9: 2290–300. |
|
| 572 | +<https://doi.org/10.1158/1078-0432.CCR-15-2123>. |
|
| 573 | + |
|
| 574 | +</div> |
|
| 575 | + |
|
| 576 | +<div id="ref-morinSomaticMutationsAltering2010a" class="csl-entry"> |
|
| 577 | + |
|
| 578 | +Morin, Ryan D., Nathalie A. Johnson, Tesa M. Severson, Andrew J. |
|
| 579 | +Mungall, Jianghong An, Rodrigo Goya, Jessica E. Paul, et al. 2010. |
|
| 580 | +“Somatic Mutations Altering EZH2 Tyr641 in Follicular and Diffuse |
|
| 581 | +Large <span class="nocase">B-cell</span> Lymphomas of Germinal-Center |
|
| 582 | +Origin.” *Nature Genetics* 42 2: 181–85. |
|
| 583 | +<https://doi.org/10.1038/ng.518>. |
|
| 584 | + |
|
| 585 | +</div> |
|
| 586 | + |
|
| 587 | +<div id="ref-morinFrequentMutationHistonemodifying2011" |
|
| 588 | +class="csl-entry"> |
|
| 589 | + |
|
| 590 | +Morin, Ryan D., Maria Mendez-Lago, Andrew J. Mungall, Rodrigo Goya, |
|
| 591 | +Karen L. Mungall, Richard D. Corbett, Nathalie A. Johnson, et al. 2011. |
|
| 592 | +“Frequent Mutation of Histone-Modifying Genes in Non-Hodgkin Lymphoma.” |
|
| 593 | +*Nature* 476 7360: 298–303. <https://doi.org/10.1038/nature10351>. |
|
| 594 | + |
|
| 595 | +</div> |
|
| 596 | + |
|
| 597 | +<div id="ref-morinMutationalStructuralAnalysis2013" class="csl-entry"> |
|
| 598 | + |
|
| 599 | +Morin, Ryan D., Karen Mungall, Erin Pleasance, Andrew J. Mungall, |
|
| 600 | +Rodrigo Goya, Ryan D. Huff, David W. Scott, et al. 2013. “Mutational and |
|
| 601 | +Structural Analysis of Diffuse Large <span class="nocase">B-cell</span> |
|
| 602 | +Lymphoma Using Whole-Genome Sequencing.” *Blood* 122 7: 1256–65. |
|
| 603 | +<https://doi.org/10.1182/blood-2013-02-483727>. |
|
| 604 | + |
|
| 605 | +</div> |
|
| 606 | + |
|
| 607 | +<div id="ref-muppidiLossSignalingGa132014b" class="csl-entry"> |
|
| 608 | + |
|
| 609 | +Muppidi, J., R. Schmitz, Jesse A. Green, Jesse A. Green, Wenming Xiao, |
|
| 610 | +Adrien B. Larsen, S. Braun, et al. 2014. “Loss of Signaling via Gα13 in |
|
| 611 | +Germinal Center B Cell-Derived Lymphoma.” *Nature* 516: 254–58. |
|
| 612 | +<https://doi.org/10.1038/nature13765>. |
|
| 613 | + |
|
| 614 | +</div> |
|
| 615 | + |
|
| 616 | +<div id="ref-nadeuGenomicEpigenomicInsights2020b" class="csl-entry"> |
|
| 617 | + |
|
| 618 | +Nadeu, F., D. Martín-García, G. Clot, A. Díaz-Navarro, M. Duran-Ferrer, |
|
| 619 | +A. Navarro, Roser Vilarrasa-Blasi, et al. 2020. “Genomic and Epigenomic |
|
| 620 | +Insights into the Origin, Pathogenesis and Clinical Behavior of Mantle |
|
| 621 | +Cell Lymphoma Subtypes.” *Blood*. |
|
| 622 | +<https://doi.org/10.1182/blood.2020005289>. |
|
| 623 | + |
|
| 624 | +</div> |
|
| 625 | + |
|
| 626 | +<div id="ref-ngoOncogenicallyActiveMYD882011a" class="csl-entry"> |
|
| 627 | + |
|
| 628 | +Ngo, Vu N., Ryan M. Young, Roland Schmitz, Sameer Jhavar, Wenming Xiao, |
|
| 629 | +Kian-Huat Lim, Holger Kohlhammer, et al. 2011. “Oncogenically Active |
|
| 630 | +MYD88 Mutations in Human Lymphoma.” *Nature* 470 7332: 115–19. |
|
| 631 | +<https://doi.org/10.1038/nature09671>. |
|
| 632 | + |
|
| 633 | +</div> |
|
| 634 | + |
|
| 635 | +<div id="ref-ohgamiSTAT3MutationsAre2014" class="csl-entry"> |
|
| 636 | + |
|
| 637 | +Ohgami, Robert S., Lisa Ma, Ahmad Monabati, James L. Zehnder, and Daniel |
|
| 638 | +A. Arber. 2014. “STAT3 Mutations Are Present in Aggressive <span |
|
| 639 | +class="nocase">B-cell</span> Lymphomas Including a Subset of Diffuse |
|
| 640 | +Large <span class="nocase">B-cell</span> Lymphomas with CD30 |
|
| 641 | +Expression.” *Haematologica* 99 7: e105–107. |
|
| 642 | +<https://doi.org/10.3324/haematol.2013.101543>. |
|
| 643 | + |
|
| 644 | +</div> |
|
| 645 | + |
|
| 646 | +<div id="ref-okosunRecurrentMTORC1activatingRRAGC2016a" |
|
| 647 | +class="csl-entry"> |
|
| 648 | + |
|
| 649 | +Okosun, Jessica, Rachel L. Wolfson, Jun Wang, Shamzah Araf, Lucy |
|
| 650 | +Wilkins, Brian M. Castellano, Leire Escudero-Ibarz, et al. 2016. |
|
| 651 | +“Recurrent <span class="nocase">mTORC1-activating RRAGC</span> Mutations |
|
| 652 | +in Follicular Lymphoma.” *Nature Genetics* 48 2: 183–88. |
|
| 653 | +<https://doi.org/10.1038/ng.3473>. |
|
| 654 | + |
|
| 655 | +</div> |
|
| 656 | + |
|
| 657 | +<div id="ref-paneaWholeGenomeLandscape2019" class="csl-entry"> |
|
| 658 | + |
|
| 659 | +Panea, R., C. Love, Jennifer R. Shingleton, Anupama Reddy, J. Bailey, A. |
|
| 660 | +Moormann, J. Otieno, et al. 2019. “The Whole Genome Landscape of Burkitt |
|
| 661 | +Lymphoma Subtypes.” *Blood*. <https://doi.org/10.1182/blood.2019001880>. |
|
| 662 | + |
|
| 663 | +</div> |
|
| 664 | + |
|
| 665 | +<div id="ref-pararajalingamCodingNoncodingDrivers2020" |
|
| 666 | +class="csl-entry"> |
|
| 667 | + |
|
| 668 | +Pararajalingam, Prasath, Krysta M. Coyle, Sarah E. Arthur, Nicole |
|
| 669 | +Thomas, Miguel Alcaide, Barbara Meissner, Merrill Boyle, et al. 2020. |
|
| 670 | +“Coding and Noncoding Drivers of Mantle Cell Lymphoma Identified Through |
|
| 671 | +Exome and Genome Sequencing.” *Blood* 136 5: 572–84. |
|
| 672 | +<https://doi.org/10.1182/blood.2019002385>. |
|
| 673 | + |
|
| 674 | +</div> |
|
| 675 | + |
|
| 676 | +<div id="ref-parryWholeExomeSequencing2013" class="csl-entry"> |
|
| 677 | + |
|
| 678 | +Parry, Marina, Matthew J. J. Rose-Zerilli, Jane Gibson, Sarah Ennis, |
|
| 679 | +Renata Walewska, Jade Forster, Helen Parker, et al. 2013. “Whole Exome |
|
| 680 | +Sequencing Identifies Novel Recurrently Mutated Genes in Patients with |
|
| 681 | +Splenic Marginal Zone Lymphoma.” *PloS One* 8 12: e83244. |
|
| 682 | +<https://doi.org/10.1371/journal.pone.0083244>. |
|
| 683 | + |
|
| 684 | +</div> |
|
| 685 | + |
|
| 686 | +<div id="ref-pasqualucciInactivationPRDM1BLIMP12006a" class="csl-entry"> |
|
| 687 | + |
|
| 688 | +Pasqualucci, Laura, Mara Compagno, Jane Houldsworth, Stefano Monti, |
|
| 689 | +Adina Grunn, Subhadra V Nandula, Jon C Aster, Vundavally V Murty, |
|
| 690 | +Margaret A Shipp, and Riccardo Dalla-Favera. 2006. “Inactivation of the |
|
| 691 | +PRDM1/BLIMP1 Gene in Diffuse Large B Cell Lymphoma.” *J Exp Med* 203 |
|
| 692 | +2: 311–17. |
|
| 693 | + |
|
| 694 | +</div> |
|
| 695 | + |
|
| 696 | +<div id="ref-pasqualucciInactivatingMutationsAcetyltransferase2011a" |
|
| 697 | +class="csl-entry"> |
|
| 698 | + |
|
| 699 | +Pasqualucci, Laura, David Dominguez-Sola, Annalisa Chiarenza, Giulia |
|
| 700 | +Fabbri, Adina Grunn, Vladimir Trifonov, Lawryn H. Kasper, et al. 2011. |
|
| 701 | +“Inactivating Mutations of Acetyltransferase Genes in <span |
|
| 702 | +class="nocase">B-cell</span> Lymphoma.” *Nature* 471 7337: 189–95. |
|
| 703 | +<https://doi.org/10.1038/nature09730>. |
|
| 704 | + |
|
| 705 | +</div> |
|
| 706 | + |
|
| 707 | +<div id="ref-pasqualucciAnalysisCodingGenome2011" class="csl-entry"> |
|
| 708 | + |
|
| 709 | +Pasqualucci, Laura, Vladimir Trifonov, Giulia Fabbri, Jing Ma, Davide |
|
| 710 | +Rossi, Annalisa Chiarenza, Victoria A. Wells, et al. 2011. “Analysis of |
|
| 711 | +the Coding Genome of Diffuse Large <span class="nocase">B-cell</span> |
|
| 712 | +Lymphoma.” *Nature Genetics* 43 9: 830–37. |
|
| 713 | +<https://doi.org/10.1038/ng.892>. |
|
| 714 | + |
|
| 715 | +</div> |
|
| 716 | + |
|
| 717 | +<div id="ref-pasqualucciHypermutationMultipleProtooncogenes2001a" |
|
| 718 | +class="csl-entry"> |
|
| 719 | + |
|
| 720 | +Pasqualucci, L., P. Neumeister, T. Goossens, G. Nanjangud, R. S. |
|
| 721 | +Chaganti, R. Küppers, and R. Dalla-Favera. 2001. “Hypermutation of |
|
| 722 | +Multiple Proto-Oncogenes in <span class="nocase">B-cell</span> Diffuse |
|
| 723 | +Large-Cell Lymphomas.” *Nature* 412 6844: 341–46. |
|
| 724 | +<https://doi.org/10.1038/35085588>. |
|
| 725 | + |
|
| 726 | +</div> |
|
| 727 | + |
|
| 728 | +<div id="ref-reddyGeneticFunctionalDrivers2017" class="csl-entry"> |
|
| 729 | + |
|
| 730 | +Reddy, Anupama, Jenny Zhang, Nicholas S Davis, Andrea B Moffitt, |
|
| 731 | +Cassandra L Love, Alexander Waldrop, Sirpa Leppa, et al. 2017. “Genetic |
|
| 732 | +and Functional Drivers of Diffuse Large B Cell Lymphoma.” *Cell* 171 |
|
| 733 | +2: 481–494.e15. |
|
| 734 | + |
|
| 735 | +</div> |
|
| 736 | + |
|
| 737 | +<div id="ref-richterRecurrentMutationID32012a" class="csl-entry"> |
|
| 738 | + |
|
| 739 | +Richter, Julia, Matthias Schlesner, Steve Hoffmann, Markus Kreuz, Ellen |
|
| 740 | +Leich, Birgit Burkhardt, Maciej Rosolowski, et al. 2012. “Recurrent |
|
| 741 | +Mutation of the ID3 Gene in Burkitt Lymphoma Identified by Integrated |
|
| 742 | +Genome, Exome and Transcriptome Sequencing.” *Nature Genetics* 44 12: |
|
| 743 | +1316–20. <https://doi.org/10.1038/ng.2469>. |
|
| 744 | + |
|
| 745 | +</div> |
|
| 746 | + |
|
| 747 | +<div id="ref-rossiCodingGenomeSplenic2012c" class="csl-entry"> |
|
| 748 | + |
|
| 749 | +Rossi, Davide, Vladimir Trifonov, Marco Fangazio, Alessio Bruscaggin, |
|
| 750 | +Silvia Rasi, Valeria Spina, Sara Monti, et al. 2012. “The Coding Genome |
|
| 751 | +of Splenic Marginal Zone Lymphoma: Activation of NOTCH2 and Other |
|
| 752 | +Pathways Regulating Marginal Zone Development.” *The Journal of |
|
| 753 | +Experimental Medicine* 209 9: 1537–51. |
|
| 754 | +<https://doi.org/10.1084/jem.20120904>. |
|
| 755 | + |
|
| 756 | +</div> |
|
| 757 | + |
|
| 758 | +<div id="ref-rushtonGeneticEvolutionaryPatterns2020" class="csl-entry"> |
|
| 759 | + |
|
| 760 | +Rushton, Christopher K., Sarah E. Arthur, Miguel Alcaide, Matthew |
|
| 761 | +Cheung, Aixiang Jiang, Krysta M. Coyle, Kirstie L. S. Cleary, et al. |
|
| 762 | +2020. “Genetic and Evolutionary Patterns of Treatment Resistance in |
|
| 763 | +Relapsed <span class="nocase">B-cell</span> Lymphoma.” *Blood Advances* |
|
| 764 | +4 13: 2886–98. <https://doi.org/10.1182/bloodadvances.2020001696>. |
|
| 765 | + |
|
| 766 | +</div> |
|
| 767 | + |
|
| 768 | +<div id="ref-russler-germainMutationsAssociatedProgression2023b" |
|
| 769 | +class="csl-entry"> |
|
| 770 | + |
|
| 771 | +Russler-Germain, David A., Kilannin Krysiak, Cody A. Ramirez, Matthew |
|
| 772 | +Mosior, Marcus P. Watkins, Felicia Gomez, Zachary L. Skidmore, et al. |
|
| 773 | +2023. “Mutations Associated with Progression in Follicular Lymphoma |
|
| 774 | +Predict Inferior Outcomes at Diagnosis: Alliance A151303.” *Blood |
|
| 775 | +Advances* 7: 5524–39. |
|
| 776 | +<https://doi.org/10.1182/bloodadvances.2023010779>. |
|
| 777 | + |
|
| 778 | +</div> |
|
| 779 | + |
|
| 780 | +<div id="ref-schmitzGeneticsPathogenesisDiffuse2018a" class="csl-entry"> |
|
| 781 | + |
|
| 782 | +Schmitz, Roland, George W. Wright, Da Wei Huang, Calvin A. Johnson, |
|
| 783 | +James D. Phelan, James Q. Wang, Sandrine Roulland, et al. 2018. |
|
| 784 | +“Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.” *The New |
|
| 785 | +England Journal of Medicine* 378 15: 1396–1407. |
|
| 786 | +<https://doi.org/10.1056/NEJMoa1801445>. |
|
| 787 | + |
|
| 788 | +</div> |
|
| 789 | + |
|
| 790 | +<div id="ref-schmitzBurkittLymphomaPathogenesis2012" class="csl-entry"> |
|
| 791 | + |
|
| 792 | +Schmitz, Roland, Ryan M. Young, Michele Ceribelli, Sameer Jhavar, |
|
| 793 | +Wenming Xiao, Meili Zhang, George Wright, et al. 2012. “Burkitt Lymphoma |
|
| 794 | +Pathogenesis and Therapeutic Targets from Structural and Functional |
|
| 795 | +Genomics.” *Nature* 490 7418: 116–20. |
|
| 796 | +<https://doi.org/10.1038/nature11378>. |
|
| 797 | + |
|
| 798 | +</div> |
|
| 799 | + |
|
| 800 | +<div id="ref-schollMutationsRegionFAS2007" class="csl-entry"> |
|
| 801 | + |
|
| 802 | +Scholl, Vanesa, Claudio Gustavo Stefanoff, Rocio Hassan, Nelson Spector, |
|
| 803 | +and Ilana Zalcberg Renault. 2007. “Mutations Within the 5’ Region of |
|
| 804 | +FAS/CD95 Gene in Nodal Diffuse Large <span class="nocase">B-cell</span> |
|
| 805 | +Lymphoma.” *Leukemia & Lymphoma* 48 5: 957–63. |
|
| 806 | +<https://doi.org/10.1080/10428190701230858>. |
|
| 807 | + |
|
| 808 | +</div> |
|
| 809 | + |
|
| 810 | +<div id="ref-shinBRAFV600EMAP2K12015" class="csl-entry"> |
|
| 811 | + |
|
| 812 | +Shin, Sang-Yong, Seung-Tae Lee, Hee-Jin Kim, Chang-Seok Ki, Chul Won |
|
| 813 | +Jung, Jong-Won Kim, and Sun-Hee Kim. 2015. “BRAF V600E and MAP2K1 |
|
| 814 | +Mutations in Hairy Cell Leukemia and Splenic Marginal Zone Lymphoma |
|
| 815 | +Cases.” *Annals of Laboratory Medicine* 35 2: 257–59. |
|
| 816 | +<https://doi.org/10.3343/alm.2015.35.2.257>. |
|
| 817 | + |
|
| 818 | +</div> |
|
| 819 | + |
|
| 820 | +<div id="ref-tanakaFrequentIncidenceSomatic1992" class="csl-entry"> |
|
| 821 | + |
|
| 822 | +Tanaka, S., D. C. Louie, J. A. Kant, and J. C. Reed. 1992. “Frequent |
|
| 823 | +Incidence of Somatic Mutations in Translocated BCL2 Oncogenes of |
|
| 824 | +Non-Hodgkin’s Lymphomas.” *Blood* 79 1: 229–37. |
|
| 825 | + |
|
| 826 | +</div> |
|
| 827 | + |
|
| 828 | +<div id="ref-thomasGeneticSubgroupsInform2023" class="csl-entry"> |
|
| 829 | + |
|
| 830 | +Thomas, Nicole, Kostiantyn Dreval, Daniela S. Gerhard, Laura K. Hilton, |
|
| 831 | +Jeremy S. Abramson, Richard F. Ambinder, Stefan Barta, et al. 2023. |
|
| 832 | +“Genetic Subgroups Inform on Pathobiology in Adult and Pediatric Burkitt |
|
| 833 | +Lymphoma.” *Blood* 141 8: 904–16. |
|
| 834 | +<https://doi.org/10.1182/blood.2022016534>. |
|
| 835 | + |
|
| 836 | +</div> |
|
| 837 | + |
|
| 838 | +<div id="ref-tiacciBRAFMutationsHairycell2011a" class="csl-entry"> |
|
| 839 | + |
|
| 840 | +Tiacci, Enrico, Vladimir Trifonov, Gianluca Schiavoni, Antony Holmes, |
|
| 841 | +Wolfgang Kern, Maria Paola Martelli, Alessandra Pucciarini, et al. 2011. |
|
| 842 | +“BRAF Mutations in Hairy-Cell Leukemia.” *The New England Journal of |
|
| 843 | +Medicine* 364 24: 2305–15. <https://doi.org/10.1056/NEJMoa1014209>. |
|
| 844 | + |
|
| 845 | +</div> |
|
| 846 | + |
|
| 847 | +<div id="ref-troenNOTCH2MutationsMarginal2008" class="csl-entry"> |
|
| 848 | + |
|
| 849 | +Trøen, Gunhild, Iwona Wlodarska, Abdirashid Warsame, Silvia Hernández |
|
| 850 | +Llodrà, Christiane De Wolf-Peeters, and Jan Delabie. 2008. “NOTCH2 |
|
| 851 | +Mutations in Marginal Zone Lymphoma.” *Haematologica* 93 7: 1107–9. |
|
| 852 | +<https://doi.org/10.3324/haematol.11635>. |
|
| 853 | + |
|
| 854 | +</div> |
|
| 855 | + |
|
| 856 | +<div id="ref-wildaInactivationARFMDM2p53Pathway2004" class="csl-entry"> |
|
| 857 | + |
|
| 858 | +Wilda, M., J. Bruch, L. Harder, D. Rawer, A. Reiter, A. Borkhardt, and |
|
| 859 | +W. Woessmann. 2004. “Inactivation of the <span |
|
| 860 | +class="nocase">ARF-MDM-2-p53</span> Pathway in Sporadic Burkitt’s |
|
| 861 | +Lymphoma in Children.” *Leukemia* 18 3: 584–88. |
|
| 862 | +<https://doi.org/10.1038/sj.leu.2403254>. |
|
| 863 | + |
|
| 864 | +</div> |
|
| 865 | + |
|
| 866 | +<div id="ref-wuGeneticHeterogeneityPrimary2016" class="csl-entry"> |
|
| 867 | + |
|
| 868 | +Wu, Chenglin, Noel Fcc de Miranda, Longyun Chen, Agata M. Wasik, Larry |
|
| 869 | +Mansouri, Wojciech Jurczak, Krystyna Galazka, et al. 2016. “Genetic |
|
| 870 | +Heterogeneity in Primary and Relapsed Mantle Cell Lymphomas: Impact of |
|
| 871 | +Recurrent CARD11 Mutations.” *Oncotarget* 7 25: 38180–90. |
|
| 872 | +<https://doi.org/10.18632/oncotarget.9500>. |
|
| 873 | + |
|
| 874 | +</div> |
|
| 875 | + |
|
| 876 | +<div id="ref-yildizActivatingSTAT6Mutations2015c" class="csl-entry"> |
|
| 877 | + |
|
| 878 | +Yildiz, Mehmet, Hongxiu Li, Denzil Bernard, Nisar A. Amin, Peter |
|
| 879 | +Ouillette, Siân Jones, Kamlai Saiya-Cork, et al. 2015. “Activating STAT6 |
|
| 880 | +Mutations in Follicular Lymphoma.” *Blood* 125 4: 668–79. |
|
| 881 | +<https://doi.org/10.1182/blood-2014-06-582650>. |
|
| 882 | + |
|
| 883 | +</div> |
|
| 884 | + |
|
| 885 | +<div id="ref-zhangGeneticHeterogeneityDiffuse2013" class="csl-entry"> |
|
| 886 | + |
|
| 887 | +Zhang, Jenny, Vladimir Grubor, Cassandra L Love, Anjishnu Banerjee, |
|
| 888 | +Kristy L Richards, Piotr A Mieczkowski, Cherie Dunphy, et al. 2013. |
|
| 889 | +“Genetic Heterogeneity of Diffuse Large <span |
|
| 890 | +class="nocase">B-cell</span> Lymphoma.” January. |
|
| 891 | + |
|
| 892 | +</div> |
|
| 893 | + |
|
| 894 | +<div id="ref-zhangGenomicLandscapeMantle2014" class="csl-entry"> |
|
| 895 | + |
|
| 896 | +Zhang, Jenny, Dereje Jima, Andrea B. Moffitt, Qingquan Liu, Magdalena |
|
| 897 | +Czader, Eric D. Hsi, Yuri Fedoriw, et al. 2014. “The Genomic Landscape |
|
| 898 | +of Mantle Cell Lymphoma Is Related to the Epigenetically Determined |
|
| 899 | +Chromatin State of Normal B Cells.” *Blood* 123 19: 2988–96. |
|
| 900 | +<https://doi.org/10.1182/blood-2013-07-517177>. |
|
| 901 | + |
|
| 902 | +</div> |
|
| 903 | + |
|
| 904 | +<div id="ref-zhouSporadicEndemicBurkitt2019" class="csl-entry"> |
|
| 905 | + |
|
| 906 | +Zhou, Peixun, Alex E. Blain, Alexander M. Newman, Masood Zaka, George |
|
| 907 | +Chagaluka, Filbert R. Adlar, Ugonna T. Offor, et al. 2019. “Sporadic and |
|
| 908 | +Endemic Burkitt Lymphoma Have Frequent FOXO1 Mutations but Distinct |
|
| 909 | +Hotspots in the AKT Recognition Motif.” *Blood Advances* 3 14: |
|
| 910 | +2118–27. <https://doi.org/10.1182/bloodadvances.2018029546>. |
|
| 911 | + |
|
| 912 | +</div> |
|
| 913 | + |
|
| 914 | +</div> |
MCL_genes.md
| ... | ... | @@ -0,0 +1,308 @@ |
| 1 | +# MCL genes |
|
| 2 | + |
|
| 3 | +## Origins of MCL genes |
|
| 4 | + |
|
| 5 | +## Tier 1 MCL genes |
|
| 6 | + |
|
| 7 | +### *23 total* |
|
| 8 | + |
|
| 9 | +| Gene | Tier | Relevant references | |
|
| 10 | +|:------------------:|:------------:|:--------------------------------------------------------------------------------:| |
|
| 11 | +| [ATM](ATM) | 1 | Beà et al. 2013; Reddy et al. 2017 | |
|
| 12 | +| [BIRC3](BIRC3) | 1 | Beà et al. 2013; Arthur et al. 2018 | |
|
| 13 | +| [CARD11](CARD11) | 1 | Lenz et al. 2008; Morin et al. 2011; Wu et al. 2016; Panea et al. 2019 | |
|
| 14 | +| [CCND1](CCND1) | 1, aSHM | Beà et al. 2013 | |
|
| 15 | +| [DAZAP1](DAZAP1) | 1 | Pararajalingam et al. 2020 | |
|
| 16 | +| [EWSR1](EWSR1) | 1 | Pararajalingam et al. 2020 | |
|
| 17 | +| [HNRNPH1](HNRNPH1) | 1, noncoding | Pararajalingam et al. 2020 | |
|
| 18 | +| [KMT2D](KMT2D) | 1 | Morin et al. 2011; Grande et al. 2019; Beà et al. 2013 | |
|
| 19 | +| [MEF2B](MEF2B) | 1 | Morin et al. 2011; Beà et al. 2013 | |
|
| 20 | +| [NFKBIE](NFKBIE) | 1 | Pararajalingam et al. 2020; Morin et al. 2016 | |
|
| 21 | +| [NOTCH1](NOTCH1) | 1 | Beà et al. 2013; Pasqualucci et al. 2011; Love et al. 2012 | |
|
| 22 | +| [NOTCH2](NOTCH2) | 1 | Panea et al. 2019; Trøen et al. 2008; Beà et al. 2013 | |
|
| 23 | +| [NSD2](NSD2) | 1 | Beà et al. 2013 | |
|
| 24 | +| [POT1](POT1) | 1 | Zhang et al. 2014 | |
|
| 25 | +| [RB1](RB1) | 1 | Zhang et al. 2014; Morin et al. 2013 | |
|
| 26 | +| [S1PR1](S1PR1) | 1 | Pararajalingam et al. 2020 | |
|
| 27 | +| [SMARCA4](SMARCA4) | 1 | Nadeu et al. 2020; Richter et al. 2012; Krysiak et al. 2017; Zhang et al. 2013 | |
|
| 28 | +| [SP140](SP140) | 1 | Beà et al. 2013 | |
|
| 29 | +| [SYNE1](SYNE1) | 1 | Nadeu et al. 2020 | |
|
| 30 | +| [TERT](TERT) | 1, noncoding | Nadeu et al. 2020 | |
|
| 31 | +| [TLR2](TLR2) | 1 | Chapuy et al. 2018; Beà et al. 2013 | |
|
| 32 | +| [TP53](TP53) | 1 | Morin et al. 2011; Beà et al. 2013; Wilda et al. 2004 | |
|
| 33 | +| [UBR5](UBR5) | 1 | Zhang et al. 2013; Pararajalingam et al. 2020 | |
|
| 34 | + |
|
| 35 | +## Tier 2 MCL genes |
|
| 36 | + |
|
| 37 | +### *46 total* |
|
| 38 | + |
|
| 39 | +| Gene | Tier | Relevant references | |
|
| 40 | +|:--------------------:|:----:|:--------------------------------------------------------:| |
|
| 41 | +| [ABCA3](ABCA3) | 2 | Beà et al. 2013 | |
|
| 42 | +| [ABCC9](ABCC9) | 2 | Beà et al. 2013 | |
|
| 43 | +| [ANK2](ANK2) | 2 | Zhang et al. 2014 | |
|
| 44 | +| [ARID1B](ARID1B) | 2 | Reddy et al. 2017 | |
|
| 45 | +| [ATP11C](ATP11C) | 2 | Zhang et al. 2014 | |
|
| 46 | +| [B2M](B2M) | 2 | Morin et al. 2011; Pararajalingam et al. 2020 | |
|
| 47 | +| [BCOR](BCOR) | 2 | Nadeu et al. 2020 | |
|
| 48 | +| [CDH8](CDH8) | 2 | Zhang et al. 2014 | |
|
| 49 | +| [CHMP4C](CHMP4C) | 2 | Beà et al. 2013 | |
|
| 50 | +| [COL11A1](COL11A1) | 2 | Zhang et al. 2014 | |
|
| 51 | +| [COL16A1](COL16A1) | 2 | Zhang et al. 2014 | |
|
| 52 | +| [CRYBG3](CRYBG3) | 2 | Beà et al. 2013 | |
|
| 53 | +| [CTNNA2](CTNNA2) | 2 | Zhang et al. 2014 | |
|
| 54 | +| [DCP1B](DCP1B) | 2 | Beà et al. 2013 | |
|
| 55 | +| [DHDH](DHDH) | 2 | Zhang et al. 2014 | |
|
| 56 | +| [DLC1](DLC1) | 2 | Zhang et al. 2014 | |
|
| 57 | +| [DLGAP2](DLGAP2) | 2 | Beà et al. 2013 | |
|
| 58 | +| [DNAJC6](DNAJC6) | 2 | Beà et al. 2013 | |
|
| 59 | +| [EIF2AK4](EIF2AK4) | 2 | Zhang et al. 2014 | |
|
| 60 | +| [ESX1](ESX1) | 2 | Zhang et al. 2014 | |
|
| 61 | +| [FAT4](FAT4) | 2 | Morin et al. 2013; Zhang et al. 2014 | |
|
| 62 | +| [GRIN2A](GRIN2A) | 2 | Zhang et al. 2014 | |
|
| 63 | +| [HEPH](HEPH) | 2 | Zhang et al. 2014 | |
|
| 64 | +| [KCNC2](KCNC2) | 2 | Beà et al. 2013 | |
|
| 65 | +| [KIAA1671](KIAA1671) | 2 | Beà et al. 2013 | |
|
| 66 | +| [KMT2C](KMT2C) | 2 | Zhou et al. 2019; Zhang et al. 2014; Zhang et al. 2013 | |
|
| 67 | +| [LUZP4](LUZP4) | 2 | Beà et al. 2013 | |
|
| 68 | +| [MRGPRF](MRGPRF) | 2 | Zhang et al. 2014 | |
|
| 69 | +| [NIN](NIN) | 2 | Zhang et al. 2014 | |
|
| 70 | +| [OGDHL](OGDHL) | 2 | Zhang et al. 2014 | |
|
| 71 | +| [PCDHB2](PCDHB2) | 2 | Zhang et al. 2014 | |
|
| 72 | +| [PCSK2](PCSK2) | 2 | Beà et al. 2013 | |
|
| 73 | +| [PDLIM3](PDLIM3) | 2 | Beà et al. 2013 | |
|
| 74 | +| [PLXNB3](PLXNB3) | 2 | Zhang et al. 2014 | |
|
| 75 | +| [RGS4](RGS4) | 2 | Beà et al. 2013 | |
|
| 76 | +| [ROBO2](ROBO2) | 2 | Zhang et al. 2014 | |
|
| 77 | +| [SALL3](SALL3) | 2 | Zhang et al. 2014; Love et al. 2012 | |
|
| 78 | +| [SI](SI) | 2 | Zhang et al. 2014 | |
|
| 79 | +| [SLC17A6](SLC17A6) | 2 | Beà et al. 2013 | |
|
| 80 | +| [SMARCB1](SMARCB1) | 2 | Nadeu et al. 2020 | |
|
| 81 | +| [SMC1A](SMC1A) | 2 | Zhang et al. 2014 | |
|
| 82 | +| [TBC1D26](TBC1D26) | 2 | Zhang et al. 2014 | |
|
| 83 | +| [TNRC6B](TNRC6B) | 2 | Beà et al. 2013 | |
|
| 84 | +| [TRPM6](TRPM6) | 2 | Beà et al. 2013 | |
|
| 85 | +| [ZNF117](ZNF117) | 2 | Zhang et al. 2014 | |
|
| 86 | +| [ZNF296](ZNF296) | 2 | Zhang et al. 2014 | |
|
| 87 | + |
|
| 88 | +# References |
|
| 89 | + |
|
| 90 | +<div id="refs" class="references csl-bib-body hanging-indent"> |
|
| 91 | + |
|
| 92 | +<div id="ref-arthurGenomewideDiscoverySomatic2018" class="csl-entry"> |
|
| 93 | + |
|
| 94 | +Arthur, Sarah E., Aixiang Jiang, Bruno M. Grande, Miguel Alcaide, Razvan |
|
| 95 | +Cojocaru, Christopher K. Rushton, Anja Mottok, et al. 2018. “Genome-Wide |
|
| 96 | +Discovery of Somatic Regulatory Variants in Diffuse Large <span |
|
| 97 | +class="nocase">B-cell</span> Lymphoma.” *Nature Communications* 9 1: |
|
| 98 | +4001. <https://doi.org/10.1038/s41467-018-06354-3>. |
|
| 99 | + |
|
| 100 | +</div> |
|
| 101 | + |
|
| 102 | +<div id="ref-beaLandscapeSomaticMutations2013" class="csl-entry"> |
|
| 103 | + |
|
| 104 | +Beà, Sílvia, Rafael Valdés-Mas, Alba Navarro, Itziar Salaverria, David |
|
| 105 | +Martín-Garcia, Pedro Jares, Eva Giné, et al. 2013. “Landscape of Somatic |
|
| 106 | +Mutations and Clonal Evolution in Mantle Cell Lymphoma.” *Proceedings of |
|
| 107 | +the National Academy of Sciences* 110 45: 18250–55. |
|
| 108 | +<https://doi.org/10.1073/pnas.1314608110>. |
|
| 109 | + |
|
| 110 | +</div> |
|
| 111 | + |
|
| 112 | +<div id="ref-chapuyMolecularSubtypesDiffuse2018b" class="csl-entry"> |
|
| 113 | + |
|
| 114 | +Chapuy, Bjoern, Chip Stewart, Andrew J. Dunford, Jaegil Kim, Atanas |
|
| 115 | +Kamburov, Robert A. Redd, Mike S. Lawrence, et al. 2018. “Molecular |
|
| 116 | +Subtypes of Diffuse Large B Cell Lymphoma Are Associated with Distinct |
|
| 117 | +Pathogenic Mechanisms and Outcomes.” *Nature Medicine* 24 5: 679–90. |
|
| 118 | +<https://doi.org/10.1038/s41591-018-0016-8>. |
|
| 119 | + |
|
| 120 | +</div> |
|
| 121 | + |
|
| 122 | +<div id="ref-grandeGenomewideDiscoverySomatic2019" class="csl-entry"> |
|
| 123 | + |
|
| 124 | +Grande, Bruno M., Daniela S. Gerhard, Aixiang Jiang, Nicholas B. Griner, |
|
| 125 | +Jeremy S. Abramson, Thomas B. Alexander, Hilary Allen, et al. 2019. |
|
| 126 | +“Genome-Wide Discovery of Somatic Coding and Noncoding Mutations in |
|
| 127 | +Pediatric Endemic and Sporadic Burkitt Lymphoma.” *Blood* 133 12: |
|
| 128 | +1313–24. <https://doi.org/10.1182/blood-2018-09-871418>. |
|
| 129 | + |
|
| 130 | +</div> |
|
| 131 | + |
|
| 132 | +<div id="ref-krysiakRecurrentSomaticMutations2017b" class="csl-entry"> |
|
| 133 | + |
|
| 134 | +Krysiak, Kilannin, Felicia Gomez, Brian S. White, Matthew Matlock, |
|
| 135 | +Christopher A. Miller, Lee Trani, Catrina C. Fronick, et al. 2017. |
|
| 136 | +“Recurrent Somatic Mutations Affecting <span |
|
| 137 | +class="nocase">B-cell</span> Receptor Signaling Pathway Genes in |
|
| 138 | +Follicular Lymphoma.” *Blood* 129 4: 473–83. |
|
| 139 | +<https://doi.org/10.1182/blood-2016-07-729954>. |
|
| 140 | + |
|
| 141 | +</div> |
|
| 142 | + |
|
| 143 | +<div id="ref-lenzOncogenicCARD11Mutations2008" class="csl-entry"> |
|
| 144 | + |
|
| 145 | +Lenz, Georg, R Eric Davis, Vu N Ngo, Lloyd Lam, Thaddeus C George, |
|
| 146 | +George W Wright, Sandeep S Dave, et al. 2008. “Oncogenic CARD11 |
|
| 147 | +Mutations in Human Diffuse Large B Cell Lymphoma.” *Science* 319 5870: |
|
| 148 | +1676–79. |
|
| 149 | + |
|
| 150 | +</div> |
|
| 151 | + |
|
| 152 | +<div id="ref-loveGeneticLandscapeMutations2012" class="csl-entry"> |
|
| 153 | + |
|
| 154 | +Love, Cassandra, Zhen Sun, Dereje Jima, Guojie Li, Jenny Zhang, Rodney |
|
| 155 | +Miles, Kristy L. Richards, et al. 2012. “The Genetic Landscape of |
|
| 156 | +Mutations in Burkitt Lymphoma.” *Nature Genetics* 44 12: 1321–25. |
|
| 157 | +<https://doi.org/10.1038/ng.2468>. |
|
| 158 | + |
|
| 159 | +</div> |
|
| 160 | + |
|
| 161 | +<div id="ref-morinGeneticLandscapesRelapsed2016" class="csl-entry"> |
|
| 162 | + |
|
| 163 | +Morin, Ryan D., Sarit Assouline, Miguel Alcaide, Arezoo Mohajeri, |
|
| 164 | +Rebecca L. Johnston, Lauren Chong, Jasleen Grewal, et al. 2016. “Genetic |
|
| 165 | +Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas.” |
|
| 166 | +*Clinical Cancer Research: An Official Journal of the American |
|
| 167 | +Association for Cancer Research* 22 9: 2290–300. |
|
| 168 | +<https://doi.org/10.1158/1078-0432.CCR-15-2123>. |
|
| 169 | + |
|
| 170 | +</div> |
|
| 171 | + |
|
| 172 | +<div id="ref-morinFrequentMutationHistonemodifying2011" |
|
| 173 | +class="csl-entry"> |
|
| 174 | + |
|
| 175 | +Morin, Ryan D., Maria Mendez-Lago, Andrew J. Mungall, Rodrigo Goya, |
|
| 176 | +Karen L. Mungall, Richard D. Corbett, Nathalie A. Johnson, et al. 2011. |
|
| 177 | +“Frequent Mutation of Histone-Modifying Genes in Non-Hodgkin Lymphoma.” |
|
| 178 | +*Nature* 476 7360: 298–303. <https://doi.org/10.1038/nature10351>. |
|
| 179 | + |
|
| 180 | +</div> |
|
| 181 | + |
|
| 182 | +<div id="ref-morinMutationalStructuralAnalysis2013" class="csl-entry"> |
|
| 183 | + |
|
| 184 | +Morin, Ryan D., Karen Mungall, Erin Pleasance, Andrew J. Mungall, |
|
| 185 | +Rodrigo Goya, Ryan D. Huff, David W. Scott, et al. 2013. “Mutational and |
|
| 186 | +Structural Analysis of Diffuse Large <span class="nocase">B-cell</span> |
|
| 187 | +Lymphoma Using Whole-Genome Sequencing.” *Blood* 122 7: 1256–65. |
|
| 188 | +<https://doi.org/10.1182/blood-2013-02-483727>. |
|
| 189 | + |
|
| 190 | +</div> |
|
| 191 | + |
|
| 192 | +<div id="ref-nadeuGenomicEpigenomicInsights2020b" class="csl-entry"> |
|
| 193 | + |
|
| 194 | +Nadeu, F., D. Martín-García, G. Clot, A. Díaz-Navarro, M. Duran-Ferrer, |
|
| 195 | +A. Navarro, Roser Vilarrasa-Blasi, et al. 2020. “Genomic and Epigenomic |
|
| 196 | +Insights into the Origin, Pathogenesis and Clinical Behavior of Mantle |
|
| 197 | +Cell Lymphoma Subtypes.” *Blood*. |
|
| 198 | +<https://doi.org/10.1182/blood.2020005289>. |
|
| 199 | + |
|
| 200 | +</div> |
|
| 201 | + |
|
| 202 | +<div id="ref-paneaWholeGenomeLandscape2019" class="csl-entry"> |
|
| 203 | + |
|
| 204 | +Panea, R., C. Love, Jennifer R. Shingleton, Anupama Reddy, J. Bailey, A. |
|
| 205 | +Moormann, J. Otieno, et al. 2019. “The Whole Genome Landscape of Burkitt |
|
| 206 | +Lymphoma Subtypes.” *Blood*. <https://doi.org/10.1182/blood.2019001880>. |
|
| 207 | + |
|
| 208 | +</div> |
|
| 209 | + |
|
| 210 | +<div id="ref-pararajalingamCodingNoncodingDrivers2020" |
|
| 211 | +class="csl-entry"> |
|
| 212 | + |
|
| 213 | +Pararajalingam, Prasath, Krysta M. Coyle, Sarah E. Arthur, Nicole |
|
| 214 | +Thomas, Miguel Alcaide, Barbara Meissner, Merrill Boyle, et al. 2020. |
|
| 215 | +“Coding and Noncoding Drivers of Mantle Cell Lymphoma Identified Through |
|
| 216 | +Exome and Genome Sequencing.” *Blood* 136 5: 572–84. |
|
| 217 | +<https://doi.org/10.1182/blood.2019002385>. |
|
| 218 | + |
|
| 219 | +</div> |
|
| 220 | + |
|
| 221 | +<div id="ref-pasqualucciAnalysisCodingGenome2011" class="csl-entry"> |
|
| 222 | + |
|
| 223 | +Pasqualucci, Laura, Vladimir Trifonov, Giulia Fabbri, Jing Ma, Davide |
|
| 224 | +Rossi, Annalisa Chiarenza, Victoria A. Wells, et al. 2011. “Analysis of |
|
| 225 | +the Coding Genome of Diffuse Large <span class="nocase">B-cell</span> |
|
| 226 | +Lymphoma.” *Nature Genetics* 43 9: 830–37. |
|
| 227 | +<https://doi.org/10.1038/ng.892>. |
|
| 228 | + |
|
| 229 | +</div> |
|
| 230 | + |
|
| 231 | +<div id="ref-reddyGeneticFunctionalDrivers2017" class="csl-entry"> |
|
| 232 | + |
|
| 233 | +Reddy, Anupama, Jenny Zhang, Nicholas S Davis, Andrea B Moffitt, |
|
| 234 | +Cassandra L Love, Alexander Waldrop, Sirpa Leppa, et al. 2017. “Genetic |
|
| 235 | +and Functional Drivers of Diffuse Large B Cell Lymphoma.” *Cell* 171 |
|
| 236 | +2: 481–494.e15. |
|
| 237 | + |
|
| 238 | +</div> |
|
| 239 | + |
|
| 240 | +<div id="ref-richterRecurrentMutationID32012a" class="csl-entry"> |
|
| 241 | + |
|
| 242 | +Richter, Julia, Matthias Schlesner, Steve Hoffmann, Markus Kreuz, Ellen |
|
| 243 | +Leich, Birgit Burkhardt, Maciej Rosolowski, et al. 2012. “Recurrent |
|
| 244 | +Mutation of the ID3 Gene in Burkitt Lymphoma Identified by Integrated |
|
| 245 | +Genome, Exome and Transcriptome Sequencing.” *Nature Genetics* 44 12: |
|
| 246 | +1316–20. <https://doi.org/10.1038/ng.2469>. |
|
| 247 | + |
|
| 248 | +</div> |
|
| 249 | + |
|
| 250 | +<div id="ref-troenNOTCH2MutationsMarginal2008" class="csl-entry"> |
|
| 251 | + |
|
| 252 | +Trøen, Gunhild, Iwona Wlodarska, Abdirashid Warsame, Silvia Hernández |
|
| 253 | +Llodrà, Christiane De Wolf-Peeters, and Jan Delabie. 2008. “NOTCH2 |
|
| 254 | +Mutations in Marginal Zone Lymphoma.” *Haematologica* 93 7: 1107–9. |
|
| 255 | +<https://doi.org/10.3324/haematol.11635>. |
|
| 256 | + |
|
| 257 | +</div> |
|
| 258 | + |
|
| 259 | +<div id="ref-wildaInactivationARFMDM2p53Pathway2004" class="csl-entry"> |
|
| 260 | + |
|
| 261 | +Wilda, M., J. Bruch, L. Harder, D. Rawer, A. Reiter, A. Borkhardt, and |
|
| 262 | +W. Woessmann. 2004. “Inactivation of the <span |
|
| 263 | +class="nocase">ARF-MDM-2-p53</span> Pathway in Sporadic Burkitt’s |
|
| 264 | +Lymphoma in Children.” *Leukemia* 18 3: 584–88. |
|
| 265 | +<https://doi.org/10.1038/sj.leu.2403254>. |
|
| 266 | + |
|
| 267 | +</div> |
|
| 268 | + |
|
| 269 | +<div id="ref-wuGeneticHeterogeneityPrimary2016" class="csl-entry"> |
|
| 270 | + |
|
| 271 | +Wu, Chenglin, Noel Fcc de Miranda, Longyun Chen, Agata M. Wasik, Larry |
|
| 272 | +Mansouri, Wojciech Jurczak, Krystyna Galazka, et al. 2016. “Genetic |
|
| 273 | +Heterogeneity in Primary and Relapsed Mantle Cell Lymphomas: Impact of |
|
| 274 | +Recurrent CARD11 Mutations.” *Oncotarget* 7 25: 38180–90. |
|
| 275 | +<https://doi.org/10.18632/oncotarget.9500>. |
|
| 276 | + |
|
| 277 | +</div> |
|
| 278 | + |
|
| 279 | +<div id="ref-zhangGeneticHeterogeneityDiffuse2013" class="csl-entry"> |
|
| 280 | + |
|
| 281 | +Zhang, Jenny, Vladimir Grubor, Cassandra L Love, Anjishnu Banerjee, |
|
| 282 | +Kristy L Richards, Piotr A Mieczkowski, Cherie Dunphy, et al. 2013. |
|
| 283 | +“Genetic Heterogeneity of Diffuse Large <span |
|
| 284 | +class="nocase">B-cell</span> Lymphoma.” January. |
|
| 285 | + |
|
| 286 | +</div> |
|
| 287 | + |
|
| 288 | +<div id="ref-zhangGenomicLandscapeMantle2014" class="csl-entry"> |
|
| 289 | + |
|
| 290 | +Zhang, Jenny, Dereje Jima, Andrea B. Moffitt, Qingquan Liu, Magdalena |
|
| 291 | +Czader, Eric D. Hsi, Yuri Fedoriw, et al. 2014. “The Genomic Landscape |
|
| 292 | +of Mantle Cell Lymphoma Is Related to the Epigenetically Determined |
|
| 293 | +Chromatin State of Normal B Cells.” *Blood* 123 19: 2988–96. |
|
| 294 | +<https://doi.org/10.1182/blood-2013-07-517177>. |
|
| 295 | + |
|
| 296 | +</div> |
|
| 297 | + |
|
| 298 | +<div id="ref-zhouSporadicEndemicBurkitt2019" class="csl-entry"> |
|
| 299 | + |
|
| 300 | +Zhou, Peixun, Alex E. Blain, Alexander M. Newman, Masood Zaka, George |
|
| 301 | +Chagaluka, Filbert R. Adlar, Ugonna T. Offor, et al. 2019. “Sporadic and |
|
| 302 | +Endemic Burkitt Lymphoma Have Frequent FOXO1 Mutations but Distinct |
|
| 303 | +Hotspots in the AKT Recognition Motif.” *Blood Advances* 3 14: |
|
| 304 | +2118–27. <https://doi.org/10.1182/bloodadvances.2018029546>. |
|
| 305 | + |
|
| 306 | +</div> |
|
| 307 | + |
|
| 308 | +</div> |